Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
SIGA Technologies is a drug manufacturers-specialty & generic business based in the US. SIGA Technologies shares (SIGA) are listed on the NASDAQ and all prices are listed in US Dollars. SIGA Technologies employs 39 staff and has a trailing 12-month revenue of around $214.8 million.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $7.41 |
|---|---|
| 52-week range | $5.49 - $26.99 |
| 50-day moving average | $7.98 |
| 200-day moving average | $11.12 |
| Wall St. target price | $11.00 |
| PE ratio | 5.1871 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.39 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $7.41 from 2023-02-01
| 1 week (2023-01-26) | -1.33% |
|---|---|
| 1 month (2022-12-30) | 0.68% |
| 3 months (2022-11-02) | -13.54% |
| 6 months (2022-08-02) | -60.56% |
| 1 year (2022-01-29) | N/A |
|---|---|
| 2 years (2021-02-02) | 8.49% |
| 3 years (2020-01-31) | 43.88% |
| 5 years (2018-02-02) | 48.20% |
Valuing SIGA Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SIGA Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SIGA Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, SIGA Technologies shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
SIGA Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $139 million.
The EBITDA is a measure of a SIGA Technologies's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $214.8 million |
|---|---|
| Operating margin TTM | 64.5% |
| Gross profit TTM | $106.4 million |
| Return on assets TTM | 50.96% |
| Return on equity TTM | 77.17% |
| Profit margin | 50.25% |
| Book value | $2.37 |
| Market capitalisation | $534.4 million |
TTM: trailing 12 months
Dividend payout ratio: 95.74% of net profits
Recently SIGA Technologies has paid out, on average, around 95.74% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), SIGA Technologies shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In SIGA Technologies's case, that would currently equate to about $0 per share.
SIGA Technologies's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
SIGA Technologies's most recent dividend payout was on 1 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 15 May 2022 (the "ex-dividend date").
Over the last 12 months, SIGA Technologies's shares have ranged in value from as little as $5.4877 up to $26.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SIGA Technologies's is 0.7883. This would suggest that SIGA Technologies's shares are less volatile than average (for this exchange).
SIGA Technologies, Inc. , a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York. .
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.